Pharmaceutical Promotion, Quality and Governance

  • Md. Faruk ShahEmail author


This chapter focuses on how the pharmaceutical industry in Bangladesh is advancing rapidly in terms of production and supply of medicine. The marketing strategy of the companies is very competitive in terms of giving gifts to doctors and generating prescriptions. This leads to the examination of such questions as: Who is it that bears the cost of such institutionalized practice? How do medical representatives (MRs) work as key players in the entire process, as well as in becoming part of capitalist exploitation? MRs play a key role in product movement in the pharmaceutical market. However, they may be considered as both agents and victims of structural violence. The professional difficulties that they experience regularly are overlooked by the majority of companies. In this case, I explore the questions: What are the reasons for this behaviour by the companies? Moreover, some pharmaceutical companies do not adhere to the regulations in regard to bioethics and drug ordinance and produce the substandard medicine that is sold mainly in the rural areas of the country. Against the backdrop, this chapter aims to explore the marketing and sales strategies of companies and the way in which a commercial network of diverse actors influences the patterns of distribution to, prescriptions for, and consumption by health seekers.


  1. Alam, F. (2014). Vezal oushud utpadon bondho hosche na [Adultered drugs manufacturing are not being stopped]. Amader Scholar
  2. BHW (Bangladesh Health Watch). (2010). How healthy is health sector governance? Dhaka: The University Press Limited.Google Scholar
  3. DGDA (Directorate General of Drug Administration). (2018). Annual report 2017–18. Dhaka: DGDA.Google Scholar
  4. Faroque, A. B. M. (2011). Biomedical consideration in the manufacture, clinical trail and bioequivalence studies of pharmaceuticals. Bangladesh Journal of Bioethics, 2(1), 18–21.CrossRefGoogle Scholar
  5. Greffion, J. (2011). Mastering time: How doctors and pharmaceutical sales representatives interact and communicate. Medische Antropologie, 23(2), 255–262.Google Scholar
  6. Haq, M.-N. (2009). Ticto Oshudh, Rugna Chikitsa O Jimmi Janagon [Bitter medicine, poor healthcare and confined people]. Dhaka: Songhoti Prokason.Google Scholar
  7. Kamat, V., & Nichter, M. (1998). Pharmacies, self-medication and pharmaceutical marketing in Bombay, India. Social Science & Medicine, 47(6), 779–794.Google Scholar
  8. Lakoff, A. (2006). High contact: Gifts and surveillance in Argentina. In A. Petryna, A. Lakoff, & A. Klienman (Eds.), Global pharmaceuticals: Ethics, markets, practices. London: Duke University Press.Google Scholar
  9. Lexchin, J. (1989). Doctors and detailers: Therapeutic education or pharmaceutical promotion. International Journal of Health Services, 19(4), 105–134.CrossRefGoogle Scholar
  10. Lexchin, J. (1992). Pharmaceutical promotion in the Third World. The Journal of Drug Issues, 22(2), 417–453.CrossRefGoogle Scholar
  11. Mamun, M. E. A., & Mamun, A. L. (2018). Gift as a promotional material and the related prescription behaviour of physicians in Bangladesh pharmaceutical market. World Journal of Pharmacy and Pharmaceutical Sciences, 7(1), 106–119.Google Scholar
  12. MOHFW (Ministry of Health and Family Welfare). (2016). National Drug Policy 2016. Dhaka: Ministry of Health and Family Welfare, Government of the People’s Republic of Bangladesh.Google Scholar
  13. Moral, S. (2010, April 3). Oshudher jodessha babohare shashthojhuki barse [Health hazards are increasing due to the irrational use of drugs]. Prothom Alo, p. 1.Google Scholar
  14. Napti, P. R. (2016). Promotional efforts of pharmaceutical industries on prescribing pattern of antibiotics among medical doctors in Nepal. Journal of Business and Social Sciences Research (JBSSR), 1(2), 201–214.CrossRefGoogle Scholar
  15. Oldani, M. J. (2004). Thick prescriptions: Towards an interpretation of pharmaceutical sales practices. Medical Anthropology Quarterly, 18(3), 326–356.CrossRefGoogle Scholar
  16. Reich, M. R. (1994). Bangladesh pharmaceutical policy and politics. Health Policy and Planning, 9(2), 130–143.CrossRefGoogle Scholar
  17. Sultana, S., & Khosru, K. H. (2011). Practice of using gifts as promotional materials for marketing of pharmaceutical products in Bangladesh: A survey conducted on general physicians and representatives from pharmaceutical companies. Stamford Journal of Pharmaceutical Sciences, 4(2), 13–18.CrossRefGoogle Scholar
  18. Sutradhur, K. B., Saha, A., Huda, N. H., & Uddin, R. (2014). Irrational use of antibiotics and antibiotic resistance in southern rural Bangladesh: Perspectives from both the physicians and patients. Annual Research and Review in Biology, 4(9), 1421–1430.CrossRefGoogle Scholar
  19. TIB (Transparency International Bangladesh). (2012). Corruption in service sectors: National household survey 2012. Dhaka: TIB.Google Scholar
  20. TIB (Transparency International Bangladesh). (2015). Governance of the directorate of drug administration: Challenges & way forward. Dhaka: TIB.Google Scholar
  21. Van der Geest, S., Whyte, S. R., & Hardon, A. (1996). The anthropology of pharmaceuticals: A biographical approach. Annual Review of Anthropology, 25, 153–178.CrossRefGoogle Scholar
  22. Wazana, A. (2000). Physicians and the pharmaceutical industry: Is a gift ever just a gift? Journal of the American Medical Association, 283(3), 373–380.CrossRefGoogle Scholar
  23. Workneh, B. D., Gebrehiwot, M. G., Bayo, T. A., Gidey, M. T., Belay, Y. B., Tesfaye, D. M., et al. (2016). Influence of medical representatives on prescribing practices in Mekelle, Northern Ethiopia. PLoS One, 11(6), e0156795.CrossRefGoogle Scholar

Copyright information

© The Author(s) 2020

Authors and Affiliations

  1. 1.Department of Development StudiesUniversity of DhakaDhakaBangladesh

Personalised recommendations